Mexico publishes regulations for the production and medicinal use of cannabis

The regulation, signed by AMLO, was published in the Official Gazette of the Federation and will allow companies to conduct medical research on cannabis products.
Mexico publishes regulations for the production and medicinal use of cannabis
Image credit: Depositphotos.com

Free Book Preview Cannabis Capital

Learn how to get your business funded in the Cannabis economy!
Entrepreneur Staff
2 min read
This article was translated from our Spanish edition using AI technologies. Errors may exist due to this process.

This Tuesday the government of Mexico published the official regulations for the production, research and medicinal use of cannabis in hopes that this year Congress will finally debate to decriminalize the total use of the plant throughout the republic.

The regulation, signed by President Andrés Manuel López Obrador , was published in the Official Gazette of the Federation and will allow companies to conduct medical research on cannabis products.

In November 2020, the Senate approved the legalization of marijuana for recreational, scientific, medical and industrial uses. This bill must be discussed in its final approval in the Chamber of Deputies, a debate that was postponed until later in 2021.

This new regulation indicates that it will be possible to investigate for the manufacture of pharmacological derivatives and medicines, and doctors for the realization of diagnoses, preventive, therapeutic, rehabilitation and palliative care ".

With more than three years of delay, the Federal Government, through the Ministry of Health and the Federal Commission for the Protection against Sanitary Risks, gave an account of the long-awaited regulation, which will favor medical advances and scientific research on the matter, as well as the development of the nascent cannabis industry.

The actions regulated by this new regulation include:

 

I. Primary production to supply the manufacture of supplies for the realization of diagnoses, preventive, therapeutic, rehabilitation and palliative care, as well as generating raw material for research and seed production.

II. Research for health.

III. Pharmacological research.

IV. Manufacture of pharmacological derivatives and medicines.

V. Doctors for the realization of diagnoses, preventive, therapeutic, rehabilitation and palliative care.

This regulation was pending since 2017 , when the Congress of the Union approved the reforms to the General Health Law to incorporate the medical and scientific use of cannabis and its derivatives. However, for political reasons and due to omissions of the authorities, the regulation was delayed until, in August 2019, after an injunction won by Carlos Avilés Garfias, son of the activist Margarita Garfias, the Supreme Court of Justice of the Nation ordered the Ministry of Health to publish the regulations within 180 business days. Finally, due to the pandemic and the consequent suspension of court terms, the delay lasted until January 12, 2021.

With information from Canncura.

More from Green Entrepreneur
David provides constructive insight to help businesses focus on their company growth, build brand awareness and know when and how to raise money.
Each week hear inspiring stories of business owners who have taken the cannabis challenge and are now navigating the exciting but unpredictable Green Rush.
Sign up for our weekly newsletter for winning strategies, exclusive features and all the tools you need to strike gold in the Green Rush.

Latest on Green Entrepreneur